Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.
Bull Exp Biol Med. 2024 Jan;176(3):403-406. doi: 10.1007/s10517-024-06033-y. Epub 2024 Feb 12.
We studied the expression of insulin-like growth factor 1 (IGF-1), androgen receptor (AR) and luteinizing hormone receptor (LHR) in the ovaries under the conditions of the modeling and subsequent treatment of functional ovarian cysts with gonadotropin-releasing hormone antagonist (ant-GnRH). The intensity of IGF-1, LHR, and AR expression in the generative elements of rat ovaries changed under conditions of functional ovarian cysts simulation, as well as during treatment with ant-GnRH. In both experimental groups, the expression levels of the studied markers in preantral follicles and epithelial lining of cysts were found to be related to the number of growing follicles and cysts. A divergence of LHR and AR expression indices and a more pronounced decrease in the number of cystic cavities were observed in the group receiving ant-GnRH. These changes demonstrate a positive effect of ant-GnRH on intra-ovarian regulatory factors and a therapeutic effect in functional ovarian cysts.
我们研究了在使用促性腺激素释放激素拮抗剂(ant-GnRH)对功能性卵巢囊肿进行建模和后续治疗的条件下,卵巢中胰岛素样生长因子 1(IGF-1)、雄激素受体(AR)和黄体生成素受体(LHR)的表达。在功能性卵巢囊肿模拟条件下,以及在使用 ant-GnRH 治疗期间,大鼠卵巢生殖元素中 IGF-1、LHR 和 AR 的表达强度发生了变化。在这两个实验组中,研究标记物在前窦卵泡和囊肿上皮衬里中的表达水平与生长卵泡和囊肿的数量有关。在接受 ant-GnRH 的组中,观察到 LHR 和 AR 表达指数的差异以及囊腔数量的更明显减少。这些变化表明 ant-GnRH 对卵巢内调节因子具有积极影响,并对功能性卵巢囊肿具有治疗效果。